Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cervical cancer
Trial Status:  Active
Results 1-25 of 366 for your search:
Start Over
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
Phase: Phase IV
Type: Prevention
Status: Approved-not yet active
Age: 13 to 15
Sponsor: Other
Protocol IDs: 37207, NCT01021904
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Phase: Phase IV
Type: Prevention
Status: Active
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109823, 2013-003429-28, NCT01031069
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Phase: Phase IV
Type: Prevention
Status: Active
Age: 11 to 17
Sponsor: Other
Protocol IDs: GardasilMerckGomez-Lobo, NCT01101750
A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 19 and over
Sponsor: Other
Protocol IDs: Oral Zinc RTC, H11-01758, NCT01468636
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
Phase: Phase IV
Type: Prevention
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: CIHR-MOP-125949, IIS #38265, NCT01824537
Influence of Gum Chewing on Postoperative Bowel Activity After Complete Staging Surgery for Gynecological Malignancies
Phase: Phase IV
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: gungorduk14, NCT01835119
CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study)
Phase: Phase IV
Type: Screening
Status: Active
Age: 30 to 64
Sponsor: Pharmaceutical / Industry
Protocol IDs: TRIUC1312, UMIN000010843, NCT01895517
Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer
Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: P110903, NCT01946672
Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GYNEOCC2, NCT01953107
Recovery and Analgesia After Surgery for Gynecological Cancer
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: Speed, NCT02026687
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: INTERTECC, R21CA162718-01, NCT01554397
Pelvic Floor Rehabilitation for Gynecological Cancer Patients
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: B-0906/077-010, NCT01871688
Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: XJFL-201309-CCPOSTOP, NCT01999933
Evaluation of Long Term Immunity Following HPV Vaccination
Phase: Phase III, Phase II
Type: Natural history/Epidemiology
Status: Active
Age: 15 to 17
Sponsor: Other
Protocol IDs: 2014.5.FNRERC.5.SU, NCT02276521
Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: E33022, NCT00122746
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: R05-0076, NCT00207298
Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 119 of 2003, NCT00193739
Prospective Randomized Open Label Study of the Treatment of Therapy-Associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium -
Phase: Phase III
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
Hydralazine Valproate for Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 006/027/ICI, NCT00532818
Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 21 and over
Sponsor: Other
Protocol IDs: Cervix Cancer Research, NCT00548821
Laparoscopic Approach to Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: LACC001, NCT00614211
The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 0014-08-RMC, NCT00726635
A Multicenter Trial of Benefits of Adding Post-surgery Chemotherapy for Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2008049, NCT00806117
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0724, CDR0000654709, NCI-2011-01973, NCT00980954
Comparing Study Between Concurrent Chemoradiation and New Combination Treatment in Cervical Cancer Patients
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: TGOC-03, ECPSU-522231012, NCT01000415
Start Over